-
1
-
-
33749440615
-
A very effective treatment for neovascular macular degeneration
-
10.1056/NEJMe068191 17021326
-
Stone EM A very effective treatment for neovascular macular degeneration N Engl J Med 2006, 355:1493-1495. 10.1056/NEJMe068191 17021326
-
(2006)
N Engl J Med
, vol.355
, pp. 1493-1495
-
-
Stone, E.M.1
-
2
-
-
33749445317
-
Ranibizumab for neovascular age-related macular degeneration
-
10.1056/NEJMoa054481 17021318
-
Rosenfeld PJ Brown DM Heier JS Boyer DS Kaiser PK Chung CY Kim RY Ranibizumab for neovascular age-related macular degeneration N Engl J Med 2006, 355:1419-1431. 10.1056/NEJMoa054481 17021318
-
(2006)
N Engl J Med
, vol.355
, pp. 1419-1431
-
-
Rosenfeld, P.J.1
Brown, D.M.2
Heier, J.S.3
Boyer, D.S.4
Kaiser, P.K.5
Chung, C.Y.6
Kim, R.Y.7
-
3
-
-
33749451356
-
Ranibizumab versus verteporfin for neovascular age-related macular degeneration
-
10.1056/NEJMoa062655 17021319
-
Brown DM Kaiser PK Michels M Soubrane G Heier JS Kim RY Sy JP Schneider S Ranibizumab versus verteporfin for neovascular age-related macular degeneration N Engl J Med 2006, 355:1432-1444. 10.1056/NEJMoa062655 17021319
-
(2006)
N Engl J Med
, vol.355
, pp. 1432-1444
-
-
Brown, D.M.1
Kaiser, P.K.2
Michels, M.3
Soubrane, G.4
Heier, J.S.5
Kim, R.Y.6
Sy, J.P.7
Schneider, S.8
-
4
-
-
33749426139
-
The price of sight - Ranibizumab, bevacizumab, and the treatment of macular degeneration
-
10.1056/NEJMp068185 17021315
-
Steinbrook R The price of sight - ranibizumab, bevacizumab, and the treatment of macular degeneration N Engl J Med 2006, 355:1409-1412. 10.1056/NEJMp068185 17021315
-
(2006)
N Engl J Med
, vol.355
, pp. 1409-1412
-
-
Steinbrook, R.1
-
6
-
-
33947403618
-
An Optical Coherence Tomography-Guided, Variable Dosing Regimen with Intravitreal Ranibizumab (Lucentis) for Neovascular Age-related Macular Degeneration
-
10.1016/j.ajo.2007.01.028 17386270
-
Fung AE Lalwani GA Rosenfeld PJ Dubovy SR Michels S Feuer WJ Puliafito CA Davis JL Flynn J Esquiabro M An Optical Coherence Tomography-Guided, Variable Dosing Regimen with Intravitreal Ranibizumab (Lucentis) for Neovascular Age-related Macular Degeneration Am J Ophthalmol 2007, 143:566-583. 10.1016/j.ajo.2007.01.028 17386270
-
(2007)
Am J Ophthalmol
, vol.143
, pp. 566-583
-
-
Fung, A.E.1
Lalwani, G.A.2
Rosenfeld, P.J.3
Dubovy, S.R.4
Michels, S.5
Feuer, W.J.6
Puliafito, C.A.7
Davis, J.L.8
Flynn, J.9
Esquiabro, M.10
-
7
-
-
33847226702
-
-
Williamstown, MA, TreeAge Software Inc
-
TreeAge Pro 2006 User's Manual Williamstown, MA, TreeAge Software Inc; 2006.
-
(2006)
TreeAge Pro 2006 User's Manual
-
-
-
10
-
-
0142244325
-
Clinical effectiveness and cost-utility of photodynamic therapy for wet age-related macular degeneration: A systematic review and economic evaluation
-
12709292
-
Meads C Salas C Roberts T Moore D Fry-Smith A Hyde C Clinical effectiveness and cost-utility of photodynamic therapy for wet age-related macular degeneration: A systematic review and economic evaluation Health Technol Assess 2003, 7:v-98. 12709292
-
(2003)
Health Technol Assess
, vol.7
-
-
Meads, C.1
Salas, C.2
Roberts, T.3
Moore, D.4
Fry-Smith, A.5
Hyde, C.6
-
11
-
-
0842267227
-
Fluorescein angiographic lesion type frequency in neovascular age-related macular degeneration
-
10.1016/j.ophtha.2003.05.030 15019371
-
Olsen TW Feng X Kasper TJ Rath PP Steuer ER Fluorescein angiographic lesion type frequency in neovascular age-related macular degeneration, Ophthalmology 2004, 111:250-255. 10.1016/j.ophtha.2003.05.030 15019371
-
(2004)
Ophthalmology
, vol.111
, pp. 250-255
-
-
Olsen, T.W.1
Feng, X.2
Kasper, T.J.3
Rath, P.P.4
Steuer, E.R.5
-
12
-
-
33749440219
-
Mechanisms of disease: Age-related macular degeneration
-
10.1056/NEJMra062326 17021323
-
de Jong PTVM Mechanisms of disease: Age-related macular degeneration N Engl J Med 2006, 355:1474-1485. 10.1056/NEJMra062326 17021323
-
(2006)
N Engl J Med
, vol.355
, pp. 1474-1485
-
-
de Jong, P.T.V.M.1
-
14
-
-
0033499369
-
Enlargement of atrophy and visual acuity loss in the geographic atrophy form of age-related macular degeneration
-
10.1016/S0161-6420(99)90340-8 10485549
-
Sunness JS Gonzalez-Baron J Applegate CA Bressler NM Tian Y Hawkins B Barron Y Bergman A Enlargement of atrophy and visual acuity loss in the geographic atrophy form of age-related macular degeneration Ophthalmology 1999, 106:1768-1779. 10.1016/S0161-6420(99)90340-8 10485549
-
(1999)
Ophthalmology
, vol.106
, pp. 1768-1779
-
-
Sunness, J.S.1
Gonzalez-Baron, J.2
Applegate, C.A.3
Bressler, N.M.4
Tian, Y.5
Hawkins, B.6
Barron, Y.7
Bergman, A.8
-
16
-
-
33846494063
-
Association between vision loss and higher medical care costs in Medicare beneficiaries: Costs are greater for those with progressive vision loss
-
10.1016/j.ophtha.2006.07.054 17270673
-
Javitt JC Zhou Z Willke RJ Association between vision loss and higher medical care costs in Medicare beneficiaries: Costs are greater for those with progressive vision loss Ophthalmology 2007, 114:238-245. 10.1016/j.ophtha.2006.07.054 17270673
-
(2007)
Ophthalmology
, vol.114
, pp. 238-245
-
-
Javitt, J.C.1
Zhou, Z.2
Willke, R.J.3
-
17
-
-
33845735049
-
Impact of visual impairment on use of caregiving by individuals with age-related macular degeneration
-
10.1097/01.iae.0000254890.48272.5a 17151494
-
Schmier JK Halpern MT Covert D Delgado J Sharma S Impact of visual impairment on use of caregiving by individuals with age-related macular degeneration Retina 2006, 26:1056-1062. 10.1097/ 01.iae.0000254890.48272.5a 17151494
-
(2006)
Retina
, vol.26
, pp. 1056-1062
-
-
Schmier, J.K.1
Halpern, M.T.2
Covert, D.3
Delgado, J.4
Sharma, S.5
-
19
-
-
0036596664
-
Are we blind to injuries in the visually impaired? A review of the literature
-
Inj Prev British Medical Association 1730864 12120837 10.1136/ip.8.2.155
-
Legood R Scuffham P Cryer C Are we blind to injuries in the visually impaired? A review of the literature. Inj Prev British Medical Association 2002, 8:155-160. 1730864 12120837 10.1136/ip.8.2.155
-
(2002)
Inj Prev
, vol.8
, pp. 155-160
-
-
Legood, R.1
Scuffham, P.2
Cryer, C.3
-
20
-
-
0032778397
-
Acute care hospital utilization by patients with visual impairment
-
10408461
-
Morse AR Yatzkan E Berberich B Arons RR Acute care hospital utilization by patients with visual impairment Arch Ophthalmol 1999, 117:943-949. 10408461
-
(1999)
Arch Ophthalmol
, vol.117
, pp. 943-949
-
-
Morse, A.R.1
Yatzkan, E.2
Berberich, B.3
Arons, R.R.4
-
22
-
-
0003469046
-
-
New York, Oxford University Press Gold MR, Siegel JE, Russell LB and Weinstein MC
-
Cost-effectiveness in health and medicine New York, Oxford University Press Gold MR, Siegel JE, Russell LB and Weinstein MC 1996.
-
(1996)
Cost-effectiveness in Health and Medicine
-
-
-
23
-
-
28144444941
-
Quality, innovation, and value for money. NICE and the British National Health Service
-
10.1001/jama.294.20.2618 16304076
-
Pearson SD Rawlins MD Quality, innovation, and value for money. NICE and the British National Health Service JAMA 2005, 294:2618-2622. 10.1001/ jama.294.20.2618 16304076
-
(2005)
JAMA
, vol.294
, pp. 2618-2622
-
-
Pearson, S.D.1
Rawlins, M.D.2
-
24
-
-
0037334224
-
Effectiveness and costs of interventions to lower systolic blood pressure and cholesterol: A global and regional analysis on reduction of cardiovascular-disease risk
-
The Lancet Publishing Group, a division of Elsevier Science Ltd. 9359 10.1016/S0140-6736(03)12655-4
-
Murray CJL Lauer JA Hutubessy RCW Niessen L Tomijima N Rodgers A Lawes CMM Evans DB Effectiveness and costs of interventions to lower systolic blood pressure and cholesterol: A global and regional analysis on reduction of cardiovascular-disease risk. The Lancet The Lancet Publishing Group, a division of Elsevier Science Ltd. 2003, 361:9359 717-725 10.1016/S0140-6736(03)12655-4
-
(2003)
The Lancet
, vol.361
, pp. 717-725
-
-
Murray, C.J.L.1
Lauer, J.A.2
Hutubessy, R.C.W.3
Niessen, L.4
Tomijima, N.5
Rodgers, A.6
Lawes, C.M.M.7
Evans, D.B.8
-
25
-
-
33750094121
-
Calculating QALYs, comparing QALY and DALY calculations
-
10.1093/heapol/czl018 16877455
-
Sassi F Calculating QALYs, comparing QALY and DALY calculations Health Policy Plan 2006, 21:402-408. 10.1093/heapol/czl018 16877455
-
(2006)
Health Policy Plan
, vol.21
, pp. 402-408
-
-
Sassi, F.1
-
26
-
-
0003845462
-
-
The World Factbook 2007 https://www.cia.gov/cia/publications/factbook/ geos/us.html;
-
(2007)
The World Factbook
-
-
-
27
-
-
34447281815
-
Relevance of Cost-Effectiveness Analysis to Clinicians and Policy Makers
-
10.1001/jama.298.2.221 17622605
-
Detsky AS Laupacis A Relevance of Cost-Effectiveness Analysis to Clinicians and Policy Makers JAMA 2007, 298:221-224. 10.1001/ jama.298.2.221 17622605
-
(2007)
JAMA
, vol.298
, pp. 221-224
-
-
Detsky, A.S.1
Laupacis, A.2
-
28
-
-
34548324016
-
Ranibizumab (Lucentis) versus bevacizumab (Avastin): Modelling cost effectiveness
-
10.1136/bjo.2007.116616 17431015
-
Raftery J Clegg A Jones J Tan SC Lotery A Ranibizumab (Lucentis) versus bevacizumab (Avastin): Modelling cost effectiveness Br J Ophthalmol 2007, 91:1244-1246. 10.1136/bjo.2007.116616 17431015
-
(2007)
Br J Ophthalmol
, vol.91
, pp. 1244-1246
-
-
Raftery, J.1
Clegg, A.2
Jones, J.3
Tan, S.C.4
Lotery, A.5
-
31
-
-
33846973644
-
Ranibizumab for neovascular age-related macular degeneration
-
[letter] 17310523
-
Gillies MC Wong TY Ranibizumab for neovascular age-related macular degeneration [letter] N Engl J Med 2007, 356:748-750. 17310523
-
(2007)
N Engl J Med
, vol.356
, pp. 748-750
-
-
Gillies, M.C.1
Wong, T.Y.2
-
32
-
-
33847006246
-
Ranibizumab for neovascular age-related macular degeneration
-
[authors' reply]
-
Rosenfeld PJ Brown DM Schneider S Ranibizumab for neovascular age-related macular degeneration [authors' reply] N Engl J Med 2007, 356:749-750.
-
(2007)
N Engl J Med
, vol.356
, pp. 749-750
-
-
Rosenfeld, P.J.1
Brown, D.M.2
Schneider, S.3
-
33
-
-
48949110517
-
Ranibizumab and pegaptanib for the treatment of age-related macular degeneration: A systematic review and economic evaluation
-
Colquitt JL Jones J Tan SC Takeda A Clegg AJ Price A Ranibizumab and pegaptanib for the treatment of age-related macular degeneration: A systematic review and economic evaluation Southampton Health Technology Assessments Centre 2007. http://www.nice.org.uk/nicemedia/pdf/ PegaptanibRanbizumabAssessmentReport.pdf
-
(2007)
Southampton Health Technology Assessments Centre
-
-
Colquitt, J.L.1
Jones, J.2
Tan, S.C.3
Takeda, A.4
Clegg, A.J.5
Price, A.6
|